What is Marchex Inc's earnings per share (EPS)?

Marchex Inc (MCHX) reported diluted earnings per share of -$0.12 for fiscal year 2025. This represents a -9.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Marchex Inc Financials

MCHX

FY2025 annual

Revenue $45.4M -5.6% YoY

Net Income -$5.2M -5.8% YoY

EPS (Diluted) -$0.12 -9.1% YoY

Free Cash Flow -$1.4M +2.8% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 13, 2026 Currency USD FYE December

Marchex Inc (MCHX) reported $45.4M in revenue for fiscal year 2025, down 5.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MCHX FY2025 2026-08-29

Cost structure, not growth, is the dominant mechanic: gross-margin gains have not converted into durable operating profit.

FY2024 paired revenue of $48.1M with gross margin of 64.3%, indicating a gross-cost reset rather than scale-driven improvement. In FY2025, revenue fell to $45.4M while operating margin slipped to -12.6%, showing that the fixed operating base absorbed the benefit from lower delivery costs.

Balance-sheet contraction is meaningful: total assets fell from $65.8M in FY2021 to $39.7M in FY2025, while liabilities also declined. This is consistent with a lightly leveraged structure: the current ratio was 2.4x, and reported liquidity equaled 84.7 months of FY2025 operating outflow.

Cash conversion is less negative than reported earnings: FY2025 operating cash flow was -$1.4M versus net income of -$5.2M, implying that noncash charges soften immediate cash consumption. Free cash flow was -$1.4M while capital expenditures were only $36K, confirming an operating-led cash shortfall rather than a heavy reinvestment cycle.

Financial Health Signals

Financial Health Score 50/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Marchex Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Dilution

Not available for Marchex Inc, and counted as zero in the overall score.

R&D Intensity

Revenue Progress

Burn Trend

Balance Sheet

Altman Z-Score Distress

-5.59

Marchex Inc scores -5.59, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($81.6M) relative to total liabilities ($9.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/7

Marchex Inc passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Marchex Inc reported a net loss of $5.2M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$45.4M

YoY-5.6%

5Y CAGR-2.4%

10Y CAGR-10.8%

Marchex Inc generated $45.4M in revenue in fiscal year 2025. This represents a decrease of 5.6% from the prior year.

EBITDA

-$4.4M

YoY-43.5%

Marchex Inc's EBITDA was -$4.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 43.5% from the prior year.

Net Income

-$5.2M

YoY-5.8%

Marchex Inc reported -$5.2M in net income in fiscal year 2025. This represents a decrease of 5.8% from the prior year.

EPS (Diluted)

-$0.12

YoY-9.1%

Marchex Inc earned -$0.12 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 9.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$1.4M

YoY+2.8%

Marchex Inc recorded an outflow of $1.4M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 2.8% from the prior year.

Cash & Debt

$9.9M

YoY-22.1%

5Y CAGR-21.7%

10Y CAGR-21.3%

Marchex Inc held $9.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share

Not reported for fiscal year 2025.

Shares Outstanding

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

63.4%

YoY-0.9pp

5Y CAGR+4.2pp

Marchex Inc's gross margin was 63.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the prior year.

Operating Margin

-12.6%

YoY-3.4pp

5Y CAGR+73.4pp

10Y CAGR-12.3pp

Marchex Inc's operating margin was -12.6% in fiscal year 2025, reflecting core business profitability. This is down 3.4 percentage points from the prior year.

Net Margin

-11.5%

YoY-1.2pp

5Y CAGR+63.5pp

10Y CAGR-30.2pp

Marchex Inc's net profit margin was -11.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.2 percentage points from the prior year.

Return on Equity

-17.4%

YoY-2.2pp

5Y CAGR+55.6pp

10Y CAGR-31.6pp

Marchex Inc's ROE was -17.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$9.7M

YoY-21.5%

5Y CAGR-14.2%

10Y CAGR-10.9%

Marchex Inc invested $9.7M in research and development in fiscal year 2025. This represents a decrease of 21.5% from the prior year.

Capital Expenditures

$36K

YoY-90.6%

5Y CAGR-51.6%

10Y CAGR-37.7%

Marchex Inc invested $36K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 90.6% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

MCHX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MCHX quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$44.0M	$45.4M-5.6%	$48.1M-3.6%	$49.9M-4.3%	$52.2M-2.4%	$53.5M+4.4%	$51.2M-6.0%	$54.5M-36.1%	$85.3M-5.6%	$90.3M-30.3%	$129.5M-9.4%	$143.0M-17.6%	$173.6M+17.4%	$147.8M+11.3%	$132.8M-4.3%	$138.7M
Cost of Revenue	$16.8M	$16.6M-3.2%	$17.2M-16.6%	$20.6M+0.6%	$20.5M-5.7%	$21.7M+3.9%	$20.9M+16.0%	$18.0M-62.3%	$47.8M-3.1%	$49.3M	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$27.2M	$28.8M-7.0%	$30.9M+5.5%	$29.3M-7.5%	$31.7M-0.2%	$31.8M+4.8%	$30.3M-16.9%	$36.5M-2.6%	$37.4M-8.6%	$41.0M	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$9.0M	$9.7M-21.5%	$12.4M-19.2%	$15.4M+7.0%	$14.4M-10.9%	$16.1M-23.3%	$21.0M+17.5%	$17.9M+15.9%	$15.4M-14.8%	$18.1M-36.4%	$28.4M-8.4%	$31.1M+5.1%	$29.6M+8.2%	$27.3M+17.8%	$23.2M+2.6%	$22.6M
SG&A Expenses	$10.0M	$10.8M+5.5%	$10.2M+0.4%	$10.2M+4.3%	$9.8M+5.3%	$9.3M-27.4%	$12.8M-1.7%	$13.0M+19.7%	$10.9M-19.8%	$13.6M-37.6%	$21.8M+17.5%	$18.5M-11.5%	$20.9M+8.1%	$19.4M-15.2%	$22.8M+0.8%	$22.7M
Operating Income	-$5.0M	-$5.7M-28.7%	-$4.4M+53.9%	-$9.6M-18.3%	-$8.1M+30.9%	-$11.8M+73.2%	-$44.1M-215.6%	-$14.0M-259.1%	-$3.9M+38.9%	-$6.4M+92.4%	-$83.9M-16447.7%	-$507K-128.4%	-$222K+89.4%	-$2.1M+87.8%	-$17.2M-401.2%	$5.7M
Interest Expense	N/A	N/A	N/A	$282K	N/A	$37K+23.3%	$30K	N/A	N/A	N/A	$109K+43.4%	$76K0.0%	$76K0.0%	$76K-82.6%	$438K-27.5%	$604K
Income Tax	$276K	$79K-79.2%	$380K+304.3%	$94K-48.9%	$184K-20.7%	$232K+112.1%	-$1.9M+44.9%	-$3.5M-2128.2%	-$156K-471.4%	$42K-22.2%	$54K+100.0%	$27K-99.9%	$22.5M+97765.2%	$23K-99.9%	$16.6M+559.7%	$2.5M
Net Income	-$5.5M	-$5.2M-5.8%	-$4.9M+50.1%	-$9.9M-20.2%	-$8.2M-87.8%	-$4.4M+88.6%	-$38.4M-851.2%	-$4.0M-50.9%	-$2.7M+56.0%	-$6.1M+92.8%	-$84.1M-414.6%	$26.7M+240.0%	-$19.1M-1150.6%	$1.8M+105.2%	-$35.2M-1289.5%	$3.0M
EPS (Diluted)	-$0.12	-$0.12-9.1%	-$0.11+52.2%	-$0.23-21.1%	-$0.19-90.0%	-$0.10	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$11.0M+3.6%	$10.6M-2.1%	$10.8M-5.8%	$11.5M-1.2%	$11.7M+2.2%	$11.4M-4.4%	$11.9M-5.0%	$12.6M
Cost of Revenue	$4.3M+4.1%	$4.1M-1.0%	$4.2M-1.3%	$4.2M+3.9%	$4.1M-3.1%	$4.2M-4.4%	$4.4M+3.7%	$4.2M
Gross Profit	$6.7M+3.3%	$6.5M-2.8%	$6.7M-8.4%	$7.3M-3.9%	$7.6M+5.3%	$7.2M-4.3%	$7.5M-9.5%	$8.3M
R&D Expenses	$2.0M-17.3%	$2.4M+9.2%	$2.2M-7.0%	$2.4M-5.2%	$2.5M-6.4%	$2.7M-6.0%	$2.8M-8.6%	$3.1M
SG&A Expenses	$2.7M+26.1%	$2.1M-7.1%	$2.3M-22.7%	$2.9M+19.4%	$2.5M-21.9%	$3.1M+14.2%	$2.8M+3.1%	$2.7M
Operating Income	-$346K+74.4%	-$1.4M+43.1%	-$2.4M-152.5%	-$941K-75.6%	-$536K+71.4%	-$1.9M-17.9%	-$1.6M-92.4%	-$825K
Income Tax	$111K-44.2%	$199K+426.2%	-$61K-325.9%	$27K+440.0%	$5K-95.4%	$108K-63.1%	$293K+1072.0%	$25K
Net Income	-$408K+76.3%	-$1.7M+25.6%	-$2.3M-127.3%	-$1.0M-1300.0%	$85K+104.3%	-$2.0M-3.8%	-$1.9M-129.8%	-$831K
EPS (Diluted)	-$0.01+75.0%	-$0.04+20.0%	-$0.05-150.0%	-$0.02	$0.00+100.0%	-$0.05-25.0%	-$0.04-100.0%	-$0.02

Not reported in any period shown, so not listed: Interest Expense.

MCHX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MCHX quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$39.7M-8.1%	$43.2M-9.0%	$47.5M-16.4%	$56.8M-13.7%	$65.8M-14.4%	$76.9M-38.2%	$124.5M+10.1%	$113.1M-8.7%	$123.8M-3.5%	$128.3M-37.4%	$205.0M+13.5%	$180.7M+11.4%	$162.1M+8.7%	$149.1M-32.2%	$220.1M
Current Assets	$19.0M-14.5%	$22.3M-6.4%	$23.8M-22.9%	$30.9M-17.7%	$37.5M-11.4%	$42.3M-32.2%	$62.4M-2.6%	$64.1M-47.1%	$121.1M-2.7%	$124.5M-8.2%	$135.7M+24.2%	$109.2M+68.1%	$65.0M+42.2%	$45.7M-38.8%	$74.6M
Cash & Equivalents	$9.9M-22.1%	$12.8M-12.6%	$14.6M-28.7%	$20.5M-24.4%	$27.1M-20.0%	$33.9M-18.9%	$41.7M-7.7%	$45.2M-56.6%	$104.2M+0.2%	$104.0M-4.8%	$109.2M+36.4%	$80.0M+158.9%	$30.9M+94.0%	$15.9M-57.5%	$37.4M
Accounts Receivable	$6.7M-5.7%	$7.1M-4.4%	$7.4M-11.9%	$8.4M+4.7%	$8.0M+26.7%	$6.3M-15.9%	$7.5M-53.5%	$16.2M+9.0%	$14.9M-21.5%	$18.9M-23.1%	$24.6M-5.1%	$25.9M-13.5%	$30.0M+15.5%	$26.0M-15.2%	$30.6M
Goodwill	$17.6M0.0%	$17.6M0.0%	$17.6M0.0%	$17.6M0.0%	$17.6M0.0%	$17.6M-45.7%	$32.3M+32.3%	$24.4M	$0	$0-100.0%	$63.3M-3.6%	$65.7M0.0%	$65.7M-0.2%	$65.8M-20.4%	$82.6M
Total Liabilities	$9.6M-9.2%	$10.6M-9.0%	$11.6M-8.5%	$12.7M-11.5%	$14.3M-40.9%	$24.2M-1.7%	$24.7M+36.7%	$18.0M-46.7%	$33.8M+125.5%	$15.0M-14.4%	$17.5M-28.5%	$24.5M-10.5%	$27.4M+4.5%	$26.2M-57.1%	$61.0M
Current Liabilities	$8.1M-13.0%	$9.3M-4.7%	$9.7M-19.4%	$12.1M-4.8%	$12.7M-39.5%	$21.0M+19.4%	$17.5M+18.8%	$14.8M-54.9%	$32.7M+120.2%	$14.9M-11.8%	$16.9M-27.9%	$23.4M-7.5%	$25.3M+5.4%	$24.0M-59.0%	$58.5M
Total Equity	$30.1M-7.8%	$32.6M-9.0%	$35.9M-18.7%	$44.1M-14.3%	$51.5M-2.3%	$52.7M-47.2%	$99.8M+5.1%	$95.0M+5.6%	$90.0M-20.5%	$113.3M-39.6%	$187.5M+20.1%	$156.2M+15.9%	$134.8M+9.6%	$122.9M-22.7%	$159.0M
Retained Earnings	-$331.4M-1.6%	-$326.2M-1.5%	-$321.2M-3.2%	-$311.3M-2.7%	-$303.1M-1.5%	-$298.7M-14.8%	-$260.2M-1.6%	-$256.2M-1.0%	-$253.7M-2.5%	-$247.6M-51.4%	-$163.5M+14.0%	-$190.2M-11.2%	-$171.1M+1.1%	-$173.0M-25.5%	-$137.8M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$37.6M-2.4%	$38.5M-2.9%	$39.7M-3.6%	$41.1M-2.0%	$42.0M+3.3%	$40.6M-5.9%	$43.2M-2.0%	$44.1M
Current Assets	$17.4M-3.9%	$18.1M-4.7%	$19.0M-6.7%	$20.4M-3.3%	$21.1M+5.9%	$19.9M-10.5%	$22.3M+2.2%	$21.8M
Cash & Equivalents	$8.2M-9.6%	$9.0M-9.3%	$9.9M-3.7%	$10.3M-1.6%	$10.5M+4.7%	$10.0M-21.5%	$12.8M+5.7%	$12.1M
Accounts Receivable	$7.1M+3.5%	$6.8M+2.3%	$6.7M-9.8%	$7.4M-2.2%	$7.6M-0.3%	$7.6M+7.2%	$7.1M-8.9%	$7.8M
Goodwill	$17.6M0.0%	$17.6M0.0%	$17.6M0.0%	$17.6M0.0%	$17.6M0.0%	$17.6M0.0%	$17.6M0.0%	$17.6M
Total Liabilities	$8.6M-11.3%	$9.7M+1.0%	$9.6M+4.3%	$9.2M-7.4%	$9.9M+7.4%	$9.3M-12.4%	$10.6M+6.1%	$10.0M
Current Liabilities	$7.6M-7.1%	$8.2M+1.5%	$8.1M0.0%	$8.1M-7.6%	$8.7M+9.6%	$8.0M-14.0%	$9.3M+7.0%	$8.7M
Total Equity	$29.0M+0.6%	$28.9M-4.1%	$30.1M-5.8%	$31.9M-0.3%	$32.0M+2.1%	$31.4M-3.9%	$32.6M-4.3%	$34.1M
Retained Earnings	-$333.5M-0.1%	-$333.1M-0.5%	-$331.4M-0.7%	-$329.1M-0.3%	-$328.1M0.0%	-$328.2M-0.6%	-$326.2M-0.6%	-$324.3M

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

MCHX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MCHX quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	-$752K	-$1.4M-27.5%	-$1.1M+74.9%	-$4.4M-91.8%	-$2.3M+63.9%	-$6.3M-88.0%	-$3.4M-166.2%	$5.1M+0.9%	$5.1M+198.5%	$1.7M+146.1%	-$3.7M-128.8%	$12.8M-43.1%	$22.4M+64.9%	$13.6M-31.7%	$19.9M+18.6%	$16.8M
Capital Expenditures	N/A	$36K-90.6%	$382K-72.3%	$1.4M-51.9%	$2.9M+112.1%	$1.4M-0.1%	$1.4M-16.6%	$1.6M-1.7%	$1.7M+5.7%	$1.6M+58.4%	$986K-76.0%	$4.1M+25.8%	$3.3M+7.4%	$3.0M+5.6%	$2.9M-27.5%	$4.0M
Free Cash Flow	N/A	-$1.4M+2.8%	-$1.5M+74.3%	-$5.8M-11.9%	-$5.2M+33.0%	-$7.7M-62.8%	-$4.7M-236.2%	$3.5M+2.1%	$3.4M+2515.4%	$130K+102.8%	-$4.7M-153.8%	$8.6M-54.9%	$19.2M+81.5%	$10.6M-38.0%	$17.0M+32.9%	$12.8M
Investing Cash Flow	-$1.5M	-$1.3M-207.7%	-$429K+67.3%	-$1.3M+54.2%	-$2.9M-201.3%	-$951K-196.9%	$981K+110.1%	-$9.7M+73.5%	-$36.6M-2218.5%	-$1.6M-28.8%	-$1.2M-105.6%	$21.8M+786.7%	-$3.2M-293.0%	$1.6M-50.4%	$3.3M+131.9%	-$10.4M
Financing Cash Flow	-$124K	-$97K+68.4%	-$307K-91.9%	-$160K+89.0%	-$1.5M-375.6%	$528K+109.6%	-$5.5M-391.1%	$1.9M+106.9%	-$27.4M-22058.4%	$125K+140.1%	-$312K+94.3%	-$5.5M-118.2%	$29.9M+11547.9%	-$261K+99.4%	-$44.7M-612.9%	-$6.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$21.9M	N/A	N/A	$1.7M-49.4%	$3.3M	N/A	$9.4M+219.1%	$2.9M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	$10.9M	N/A	$5.7M	N/A	$365K-90.5%	$3.8M+53.7%	$2.5M+1989.1%	$119K-92.8%	$1.7M-73.2%	$6.2M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$649K-26.3%	-$514K-524.8%	$121K-58.3%	$290K-63.9%	$803K+130.6%	-$2.6M-399.7%	$875K+129.1%	$382K
Capital Expenditures	N/A	N/A	$5K	$0	N/A	N/A	$118K-35.5%	$183K
Free Cash Flow	N/A	N/A	$116K-60.0%	$290K	N/A	N/A	$757K+280.4%	$199K
Investing Cash Flow	-$275K+33.1%	-$411K+4.0%	-$428K-22.3%	-$350K-38.3%	-$253K+12.5%	-$289K-75.2%	-$165K+9.8%	-$183K
Financing Cash Flow	$56K+2700.0%	$2K+102.8%	-$72K+34.5%	-$110K-39.2%	-$79K-148.2%	$164K+881.0%	-$21K+78.6%	-$98K

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MCHX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

MCHX quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	63.4%-0.9pp	64.3%+5.6pp	58.8%-2.0pp	60.8%+1.3pp	59.4%+0.2pp	59.2%-7.7pp	67.0%+23.0pp	43.9%-1.4pp	45.4%	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-12.6%-3.4pp	-9.2%+10.1pp	-19.3%-3.7pp	-15.6%+6.4pp	-22.1%+64.0pp	-86.0%-60.4pp	-25.6%-21.1pp	-4.6%+2.5pp	-7.0%+57.7pp	-64.8%-64.4pp	-0.4%-0.2pp	-0.1%+1.3pp	-1.4%+11.6pp	-13.0%-17.1pp	4.1%
Net Margin	-11.5%-1.2pp	-10.3%+9.6pp	-19.9%-4.1pp	-15.8%-7.6pp	-8.2%+66.9pp	-75.1%-67.6pp	-7.4%-4.3pp	-3.1%+3.6pp	-6.7%+58.1pp	-64.9%-83.6pp	18.7%+29.7pp	-11.0%-12.2pp	1.2%+27.7pp	-26.5%-28.6pp	2.1%
Return on Equity	-17.4%-2.2pp	-15.2%+12.5pp	-27.6%-8.9pp	-18.7%-10.2pp	-8.5%+64.5pp	-73.0%-68.9pp	-4.0%-1.2pp	-2.8%+3.9pp	-6.8%+67.5pp	-74.2%-88.5pp	14.2%+26.5pp	-12.2%-13.6pp	1.4%+30.0pp	-28.6%-30.5pp	1.9%
Return on Assets	-13.2%-1.7pp	-11.5%+9.4pp	-20.9%-6.3pp	-14.5%-7.8pp	-6.7%+43.3pp	-50.0%-46.7pp	-3.3%-0.9pp	-2.4%+2.6pp	-4.9%+60.6pp	-65.5%-78.6pp	13.0%+23.6pp	-10.6%-11.7pp	1.1%+24.7pp	-23.6%-24.9pp	1.3%
Current Ratio	2.360.0x	2.400.0x	2.45-0.1x	2.56-0.4x	2.96+0.9x	2.02-1.5x	3.56-0.8x	4.34+0.6x	3.70-4.7x	8.37+0.3x	8.05+3.4x	4.67+2.1x	2.57+0.7x	1.90+0.6x	1.28
Debt-to-Equity	0.320.0x	0.320.0x	0.320.0x	0.290.0x	0.28-0.2x	0.46+0.2x	0.25+0.1x	0.19-0.2x	0.38+0.2x	0.130.0x	0.09-0.1x	0.160.0x	0.200.0x	0.21-0.2x	0.38
FCF Margin	-3.2%-0.1pp	-3.1%+8.5pp	-11.6%-1.7pp	-9.9%+4.5pp	-14.4%-5.2pp	-9.2%-15.6pp	6.4%+2.4pp	4.0%+3.9pp	0.1%+3.7pp	-3.6%-9.6pp	6.0%-5.0pp	11.0%+3.9pp	7.1%-5.7pp	12.8%+3.6pp	9.2%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	61.0%-0.2pp	61.2%-0.4pp	61.6%-1.7pp	63.4%-1.8pp	65.2%+1.9pp	63.3%0.0pp	63.2%-3.1pp	66.3%
Operating Margin	-3.1%+9.6pp	-12.7%+9.2pp	-21.9%-13.7pp	-8.2%-3.6pp	-4.6%+11.8pp	-16.4%-3.1pp	-13.3%-6.7pp	-6.6%
Net Margin	-3.7%+12.5pp	-16.2%+5.1pp	-21.4%-12.5pp	-8.9%-9.6pp	0.7%+18.1pp	-17.4%-1.4pp	-16.0%-9.4pp	-6.6%
Return on Equity	-1.4%+4.6pp	-6.0%+1.7pp	-7.7%-4.5pp	-3.2%-3.5pp	0.3%+6.6pp	-6.3%-0.5pp	-5.9%-3.4pp	-2.4%
Return on Assets	-1.1%+3.4pp	-4.5%+1.4pp	-5.8%-3.4pp	-2.5%-2.7pp	0.2%+5.1pp	-4.9%-0.5pp	-4.4%-2.5pp	-1.9%
Current Ratio	2.29+0.1x	2.22-0.1x	2.36-0.2x	2.53+0.1x	2.42-0.1x	2.50+0.1x	2.40-0.1x	2.52
Debt-to-Equity	0.300.0x	0.340.0x	0.320.0x	0.290.0x	0.310.0x	0.300.0x	0.320.0x	0.29
FCF Margin	N/A	N/A	1.1%-1.5pp	2.5%	N/A	N/A	6.3%+4.8pp	1.6%

Similar Companies

THUMZUP MEDIA CORPORATION TZUP

$75.3M

Townsquare Media Inc TSQ

$105.4M

VS MEDIA Holdings VSME

$3.0M

Cardlytics CDLX

$23.7M

Entravision Communications Cp EVC

$744.8M

Where Marchex Inc Ranks

Frequently Asked Questions

What is Marchex Inc's annual revenue?

Marchex Inc (MCHX) reported $45.4M in total revenue for fiscal year 2025. This represents a -5.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Marchex Inc's revenue growing?

Marchex Inc (MCHX) revenue declined by 5.6% year-over-year, from $48.1M to $45.4M in fiscal year 2025.

Is Marchex Inc profitable?

No, Marchex Inc (MCHX) reported a net income of -$5.2M in fiscal year 2025, with a net profit margin of -11.5%.

What is Marchex Inc's EBITDA?

Marchex Inc (MCHX) had EBITDA of -$4.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Marchex Inc's gross margin?

Marchex Inc (MCHX) had a gross margin of 63.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Marchex Inc's operating margin?

Marchex Inc (MCHX) had an operating margin of -12.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Marchex Inc's net profit margin?

Marchex Inc (MCHX) had a net profit margin of -11.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Marchex Inc's return on equity (ROE)?

Marchex Inc (MCHX) has a return on equity of -17.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Marchex Inc's free cash flow?

Marchex Inc (MCHX) recorded an outflow of $1.4M in free cash flow during fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Marchex Inc's operating cash flow?

Marchex Inc (MCHX) recorded an outflow of $1.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Marchex Inc's total assets?

Marchex Inc (MCHX) had $39.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Marchex Inc's capital expenditures?

Marchex Inc (MCHX) invested $36K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Marchex Inc spend on research and development?

Marchex Inc (MCHX) invested $9.7M in research and development during fiscal year 2025.

What is Marchex Inc's current ratio?

Marchex Inc (MCHX) had a current ratio of 2.36 as of fiscal year 2025, which is generally considered healthy.

What is Marchex Inc's debt-to-equity ratio?

Marchex Inc (MCHX) had a debt-to-equity ratio of 0.32 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Marchex Inc's return on assets (ROA)?

Marchex Inc (MCHX) had a return on assets of -13.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does Marchex Inc's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Marchex Inc (MCHX) held $9.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $1.4M over that year. Dividing the one by the other, the reported balance equals about 85 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Marchex Inc's Altman Z-Score?

Marchex Inc (MCHX) has an Altman Z-Score of -5.59, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Marchex Inc's Piotroski F-Score?

Marchex Inc (MCHX) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Marchex Inc's earnings high quality?

Marchex Inc (MCHX) reported a net loss of $5.2M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Marchex Inc?

Marchex Inc (MCHX) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.